Biotalys (BTLS) Stock Overview
An agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
BTLS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Biotalys NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.01 |
| 52 Week High | €5.28 |
| 52 Week Low | €1.56 |
| Beta | 1.39 |
| 1 Month Change | -4.91% |
| 3 Month Change | 47.30% |
| 1 Year Change | -40.61% |
| 3 Year Change | -49.75% |
| 5 Year Change | -58.61% |
| Change since IPO | -57.07% |
Recent News & Updates
BTLS: Regulatory Momentum For Biofungicide Approvals Will Drive Future Upside Potential
Analysts have adjusted their fair value estimate for Biotalys from €6.70 to €5.03. This reflects updated assumptions on the discount rate, revenue growth, profit margins and future P/E multiples.
Regulatory Delays And Cost Uncertainty Will Test Biological Crop Protection Potential
Catalysts About Biotalys Biotalys develops protein based biocontrol products for crop protection, focused on biofungicides and bioinsecticides. What are the underlying business or industry changes driving this perspective?Recent updates
BTLS: Regulatory Momentum For Biofungicide Approvals Will Drive Future Upside Potential
Analysts have adjusted their fair value estimate for Biotalys from €6.70 to €5.03. This reflects updated assumptions on the discount rate, revenue growth, profit margins and future P/E multiples.Regulatory Delays And Cost Uncertainty Will Test Biological Crop Protection Potential
Catalysts About Biotalys Biotalys develops protein based biocontrol products for crop protection, focused on biofungicides and bioinsecticides. What are the underlying business or industry changes driving this perspective?
Regulatory Tailwinds And Partnerships Will Position Protein Biocontrol Platform For Significant Future Adoption
Catalysts About Biotalys Biotalys develops protein based biocontrol solutions for crop protection using its AGROBODY platform. What are the underlying business or industry changes driving this perspective?Protein Based Biocontrol Platform Will Benefit From Regulatory Tailwinds And Long Term Industry Demand
Catalysts About Biotalys Biotalys develops protein based precision biocontrol products for crop protection across fungicide and insecticide markets. What are the underlying business or industry changes driving this perspective?Does Biotalys (EBR:BTLS) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Shareholder Returns
| BTLS | BE Chemicals | BE Market | |
|---|---|---|---|
| 7D | -1.2% | 0.6% | -1.9% |
| 1Y | -40.6% | 1.5% | 22.6% |
Return vs Industry: BTLS underperformed the Belgian Chemicals industry which returned -0.7% over the past year.
Return vs Market: BTLS underperformed the Belgian Market which returned 22.7% over the past year.
Price Volatility
| BTLS volatility | |
|---|---|
| BTLS Average Weekly Movement | 9.3% |
| Chemicals Industry Average Movement | 4.3% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in BE Market | 7.0% |
| 10% least volatile stocks in BE Market | 2.2% |
Stable Share Price: BTLS's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: BTLS's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 62 | Carlo Boutton | biotalys.com |
Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products.
Biotalys NV Fundamentals Summary
| BTLS fundamental statistics | |
|---|---|
| Market cap | €112.89m |
| Earnings (TTM) | -€15.76m |
| Revenue (TTM) | n/a |
Is BTLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BTLS income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €15.76m |
| Earnings | -€15.76m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Aug 20, 2026
| Earnings per share (EPS) | -0.42 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 16.6% |
How did BTLS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/13 03:22 |
| End of Day Share Price | 2026/07/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotalys NV is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sebastian Bray | Berenberg |
| David Seynnaeve | Degroof Petercam Sponsored Research |
| Guy Sips | KBC Securities NV |